It promotes the invasion of gliomas through upregulation of the expression of matrix metalloproteinase-7 (MMP-7), matrix metalloproteinase-9 (MMP-9), and vascular endothelial growth factor (VEGF) [76]. The gene discussed is MMP9; the disease is central nervous system cancer.